ST. LOUIS, July 23, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2020 second quarter on Thursday, August 6, 2020 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10:00 a.m. Eastern Time that day to discuss the Company’s results and corporate developments.
| What: |
Stereotaxis second quarter financial results conference call |
| |
|
| When: |
Thursday, August 6, at 10:00 a.m. Eastern Time (7:00 a.m. PT) |
| |
|
| Dial In Number: |
To access the live call, dial 888-394-8218 (US and Canada) or 786-789-4776 (International) and give the participant pass code 6170258. |
| |
|
| Webcast: |
To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/ |
| |
|
| Call Replay: |
A phone replay of the call will be available for one week beginning approximately two hours following the end of the call through August 13, 2020. To request access for a replay of the conference call, please click here. |
| |
|
About Stereotaxis
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.
Company Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
314-678-6100
investors@stereotaxis.com
Source: Stereotaxis, Inc.